SCHEMBL3260842

SCHEMBL3260842

C=CC[N]C(N)C=C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL671581 0.67
SCHEMBL3264301 0.65
SCHEMBL8546999 0.65
SCHEMBL3314197 0.65
SCHEMBL8819890 0.64 ALDH1A1 (0.31)
SCHEMBL2875149 0.61
SCHEMBL220125 0.59
SCHEMBL5520093 0.59
SCHEMBL28956877 0.58
SCHEMBL5549399 0.57

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029606-B1 CYCLOPROPYL FUSED INDOLOBENZAZEPINE HCV NS5B INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2010-05-26 EP claimed
EP-2029606-A2 CYCLOPROPYL FUSED INDOLOBENZAZEPINE HCV NS5B INHIBITORS Brystol-Myers Squibb Company (US) 2009-03-04 EP claimed
US-7456167-B2 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2008-11-25 US claimed
WO-2007140254-A2 CYCLOPROPYL FUSED INDOLOBENZAZEPINE HCV NS5B INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-12-06 WO claimed
US-20070275947-A1 Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors BRISTOL-MYERS SQUIBB COMPANY 2007-11-29 US claimed
US-20070248566-A1 Antimicrobial polyisocyanate and derivatives thereof HEADWAY ADVANCED MATERIALS INC. 2007-10-25 US claimed
EP-1629864-A1 Composition for dyeing keratin fibres comprising a methine direct dye with a benzoselenazolium group L'OREAL (FR) 2006-03-01 EP claimed
WO-1994006797-A1 NOVEL BIOREDUCTIVE AGENTS BRITISH TECHNOLOGY GROUP LIMITED (GB) 1994-03-31 WO claimed
US-4347246-A Antihypertensive lactams USV PHARMACEUTICAL CORPORATION (US) 1982-08-31 US claimed
EP-2029606-B1 CYCLOPROPYL FUSED INDOLOBENZAZEPINE HCV NS5B INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2010-05-26 EP disclosed
EP-2029606-A2 CYCLOPROPYL FUSED INDOLOBENZAZEPINE HCV NS5B INHIBITORS Brystol-Myers Squibb Company (US) 2009-03-04 EP disclosed
US-7456167-B2 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2008-11-25 US disclosed
WO-2007140254-A2 CYCLOPROPYL FUSED INDOLOBENZAZEPINE HCV NS5B INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-12-06 WO disclosed
US-20070275947-A1 Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors BRISTOL-MYERS SQUIBB COMPANY 2007-11-29 US disclosed
US-20070248566-A1 Antimicrobial polyisocyanate and derivatives thereof HEADWAY ADVANCED MATERIALS INC. 2007-10-25 US disclosed
EP-1629864-A1 Composition for dyeing keratin fibres comprising a methine direct dye with a benzoselenazolium group L'OREAL (FR) 2006-03-01 EP disclosed
US-20050043313-A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade PHARMACIA CORPORATION 2005-02-24 US disclosed
WO-1994006797-A1 NOVEL BIOREDUCTIVE AGENTS BRITISH TECHNOLOGY GROUP LIMITED (GB) 1994-03-31 WO disclosed
WO-1994006797-A1 NOVEL BIOREDUCTIVE AGENTS BRITISH TECHNOLOGY GROUP LIMITED (GB) 1994-03-31 WO disclosed
EP-0416393-A1 Peptidyl difluorodiol renin inhibitors ABBOTT LABORATORIES (US) 1991-03-13 EP disclosed